Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Vivos Therapeutics (VVOS) Preferred Shares Issued (2020)

Vivos Therapeutics (VVOS) has disclosed Preferred Shares Issued for 1 consecutive years, with $349501.0 as the latest value for Q4 2020.

  • On a quarterly basis, Preferred Shares Issued changed N/A to $349501.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $2.5 million, a N/A change, with the full-year FY2020 number at $2.5 million, changed N/A from a year prior.
  • Preferred Shares Issued was $349501.0 for Q4 2020 at Vivos Therapeutics, down from $1.9 million in the prior quarter.
  • In the past five years, Preferred Shares Issued ranged from a high of $1.9 million in Q3 2020 to a low of $200.0 in Q2 2020.